PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification. (Q47975012)
Jump to navigation
Jump to search
scientific article published on 26 March 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification. |
scientific article published on 26 March 2012 |
Statements
PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification (English)
Dan Williamson
Julia Chisholm
Pratyaksha Wirapati
Gaëlle Pierron
Fabien Petel
Khin Thway
Odile Oberlin
Mauro Delorenzi
26 March 2012